MRI for kidney cancer — when a renal MRI is the better scan

Neither is better in general — they answer different questions. A contrast-enhanced CT is usually the first detailed scan for a kidney mass because it is quick, widely available, and covers the abdomen and chest in one sitting. MRI comes into its own where CT is limited or unsuitable: reduced kidney function, a previous reaction to the iodine-based CT dye, pregnancy, a cystic or indeterminate mass that CT could not settle, or a tumour that may be growing into the renal vein. NCCN guidance treats contrast-enhanced CT or MRI as the standard way to characterise a renal mass, which is another way of saying either can be the right scan. The choice depends on the question being asked and on you.

Often it can tell a great deal, but it is not a biopsy. MRI reads a mass by how it behaves — whether it takes up contrast, how water moves inside it, whether it contains fat or old blood — and those behaviours separate most benign lesions from most cancers. Hold on to the starting point: up to a third of small kidney masses turn out to be benign, so a scan that can characterise a mass confidently spares people surgery they never needed. Where imaging is genuinely undecided, the next step is a specialist re-read of the images, a uro-oncology tumour board discussion, and sometimes a biopsy — not an assumption in either direction.

Usually for a practical reason, not because something worse has been found. The commonest are reduced kidney function or a previous reaction that makes the iodine-based CT dye unsuitable; pregnancy, or a deliberate decision to avoid X-ray radiation in someone young or in someone with an inherited syndrome who will be scanned for years; a cyst or mass that a CT described but could not settle; and a suspicion that the tumour is extending into the renal vein or the vena cava, where MRI maps the upper limit of the tumour particularly well. An MRI request is a request for a clearer answer. It is not a verdict, and it is not a sign that your team has decided anything.

It is a fair question and it should be asked out loud. MRI uses a different contrast agent from CT, and the agents in routine use today are selected with kidney function in mind — the risk that gave this class of agent its old reputation is considered very low with current agents and protocols. Your kidney function is checked with a blood test first, and the radiologist and your oncologist decide together on the agent and the dose. Several useful questions can also be answered by an MRI done without contrast at all. If you have ever reacted to a scan dye, or you are on dialysis, say so when you book rather than on the day.

Longer and noisier than a CT, and that is the main thing to prepare for. You lie on a table that slides into a tunnel-shaped magnet, with no metal on you and a receiver coil resting over your abdomen. The machine knocks and thumps in bursts, so you are given headphones or earplugs. You will be asked to hold your breath for short stretches, because the kidneys move as you breathe and the pictures blur if they do. If contrast is being used, a cannula goes into a vein in your arm. Nothing about it hurts. If enclosed spaces are difficult for you, say so when you book — it can be planned for, rather than discovered halfway in.

Sometimes yes, sometimes no — and it is decided before the appointment rather than at the scanner door. Many modern cardiac devices, joint replacements, stents and surgical clips are MRI-conditional, meaning they can be scanned safely under specified conditions. Others are not, and a few things rule an MRI out altogether, including some older devices, certain aneurysm clips and metal fragments in the eye. That is exactly what the safety questionnaire is for, so answer it fully and bring any implant card or documentation you were given. If MRI turns out to be unsafe for you, a contrast-enhanced CT will usually answer the same question, and your team should say so plainly.